Caregiver-reported non-seizure and seizure outcomes with cannabidiol and clobazam in patients aged ≥2 years with Lennox-Gastaut syndrome or Dravet syndrome: A subgroup analysis of the BECOME survey.

Saved in:
Bibliographic Details
Title: Caregiver-reported non-seizure and seizure outcomes with cannabidiol and clobazam in patients aged ≥2 years with Lennox-Gastaut syndrome or Dravet syndrome: A subgroup analysis of the BECOME survey.
Authors: Perry MS; Cook Children's Medical Center, Fort Worth, TX, USA. Electronic address: Scott.Perry@cookchildrens.org., Dixon-Salazar T; Lennox-Gastaut Syndrome Foundation, San Diego, CA, USA., Meskis MA; Dravet Syndrome Foundation, Cherry Hill, NJ, USA., Danese SR; Outcomes Insights, Agoura Hills, CA, USA., Saurer TB; Jazz Pharmaceuticals, Inc., Carlsbad, CA, USA., Vyas K; Jazz Pharmaceuticals, UK Ltd., London, UK., Berg AT; Decoding Developmental Epilepsies, WA D.C., USA.
Source: Seizure [Seizure] 2025 Aug; Vol. 130, pp. 32-40. Date of Electronic Publication: 2025 May 03.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9306979 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2688 (Electronic) Linking ISSN: 10591311 NLM ISO Abbreviation: Seizure Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-2688
DOI:10.1016/j.seizure.2025.04.017